CEEGOG

AGO-OVAR 28

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane based Chemotherapy in Advanced Ovarian Cancer

Trial Number
NCT05009082
Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number

A18-00/ENGOT-CX11

A Randomized, Phase 3, Double-Blind Study of Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical Cancer

Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number